Found 205 articles for: "chemotherapy"
Topical Aprepitant (HT-001): A Novel Therapy for Epidermal Growth Factor Receptor Inhibitor-Associated Papulopustular Eruptions
September 2024 | Volume 23 | Issue 9 | Case Reports | e173 | Copyright © September 2024
Papulopustular eruptions are the most common dermatologic side effect of epidermal growth factor receptor inhibitor (EGFRI) therapy. Topical corticosteroids and oral tetracyclines are frequently ...
Read MoreCase Series of Acral and Mucosal Melanoma in a Diverse Patient Population
August 2024 | Volume 23 | Issue 8 | Case Reports | 683 | Copyright © August 2024
Melanomas affecting acral and mucosal sites have distinct features and are associated with poorer prognosis. Patients of color may be disproportionately affected. Herein we discuss six ethnically...
Read MoreMycosis Fungoides Palmaris et Plantaris Mimicking "Dyshidrotic Eczema": A Case Report
July 2024 | Volume 23 | Issue 7 | Case Reports | 569 | Copyright © July 2024
Mycosis fungoides palmaris et plantaris (MFPP) is a rare variant of mycosis fungoides (MF), a type of cutaneous T-cell lymphoma. MFPP primarily affects the palms and soles of the feet and is ofte...
Read MoreOverview of Radiation Dermatitis: The Dermatologist's Role
May 2024 | Volume 23 | Issue 5 | Features | 381 | Copyright © May 2024
Eyebrow and Eyelash Loss in Patients With Cancer
May 2024 | Volume 23 | Issue 5 | Original Article | 327 | Copyright © May 2024
Though it is widely acknowledged that cancer treatments cause hair loss on the scalp, there are limited data on how they affect eyebrow and eyelash hairs. Patients with eyebrow and eyelash loss, ...
Read MoreThe Use of Natural Therapies in Patients With Skin Cancer: A Scoping Review
May 2024 | Volume 23 | Issue 5 | Original Article | 322 | Copyright © May 2024
Complementary and alternative medicine (CAM) use has become a field of growing interest in dermatology. However, the prevalence of CAM use is difficult to quantify as it varies based on many fact...
Read MoreMetastatic Merkel Cell Carcinoma After Simultaneous Pancreas-Kidney Transplantation: Fatal Outcomes
May 2024 | Volume 23 | Issue 5 | Case Reports | 376 | Copyright © May 2024
Merkel cell carcinoma (MCC) is a rare, highly aggressive cutaneous malignancy. Immunosuppression increases the risk of MCC and is associated with poor prognosis. Organ transplant recipients (OTR)...
Read MoreHuman Clinical Trials Using Topical Bakuchiol Formulations for the Treatment of Skin Disorders: A Systematic Review
April 2024 | Volume 23 | Issue 4 | Original Article | 239 | Copyright © April 2024
Background: Bakuchiol is a topical cosmeceutical marketed as a retinoid alternative. Human clinical trial data on bakuchiol's efficacy for the treatment of dermatologic condition...
Read MoreTreatments for Moderate-to-Severe Acne Vulgaris: A Systematic Review and Network Meta-analysis
April 2024 | Volume 23 | Issue 4 | Original Article | 216 | Copyright © April 2024
Background: Multiple treatment options exist for the management of moderate-to-severe acne. However, the comparative effectiveness (efficacy/safety) of moderate-to-severe acne tr...
Read MoreEffectiveness and Safety of a New Hyaluronic Acid Injectable for Augmentation and Correction of Chin Retrusion
April 2024 | Volume 23 | Issue 4 | Original Article | 255 | Copyright © April 2024
Read MoreCutaneous Squamous Cell Carcinoma In Situ on a Fingernail Treated With HPV Vaccine
April 2024 | Volume 23 | Issue 4 | Case Reports | 275 | Copyright © April 2024
Atypical Dyschromia in Skin of Color
February 2024 | Volume 23 | Issue 2 | Case Reports | 100 | Copyright © February 2024
Dyschromia is a concern for many patients, especially persons of color. Postinflammatory hypopigmentation and depigmentation can affect all skin types; however, it is more apparent in those with ...
Read MoreNeoadjuvant PD-1 Inhibitors: A Tale of Two Cases
February 2024 | Volume 23 | Issue 2 | Case Reports | e57 | Copyright © February 2024
Treatment responses for locally advanced cutaneous squamous cell carcinoma (cSCC) and Merkel cell carcinoma (MCC) are often short lived and are marred with recurrences. The introduction of adjuva...
Read MoreIncorporating a Prognostic Gene Expression Profile Test into the Management of Cutaneous Squamous Cell Carcinoma: An Expert Consensus Panel Report
February 2024 | Volume 23 | Issue 2 | Original Article | 54 | Copyright © February 2024
Background: Cutaneous squamous cell carcinoma (cSCC) is a growing health concern with a rapidly increasing incidence. Disease-specific mortality is typically preceded by a m...
Read MoreA Massive Case of Cutaneous Diffuse Large B-Cell Lymphoma
December 2023 | Volume 22 | Issue 12 | Case Reports | 1223 | Copyright © December 2023
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma, and extranodal involvement is seen in approximately 40% of cases. However, cases involving the skin and musc...
Read MoreINDIVIDUAL ARTICLE: USCOM Algorithm for the Prevention and Management of Cutaneous Immunotherapy-Related Adverse Events
November 2023 | Volume 22 | Issue 11 | Supplement Individual Articles | SF389716s4 | Copyright © November 2023
Background: In 2023, nearly 2 million patients will be diagnosed with cancer in the United States and at least 40% will be eligible for treatment with an immune checkpoint inhibi...
Read MoreINDIVIDUAL ARTICLE: NECOM 3: A Practical Algorithm for the Management of Radiation Therapy-Related Acute Radiation Dermatitis
November 2023 | Volume 22 | Issue 11 | Supplement Individual Articles | SF400354s3 | Copyright © November 2023
Background: In the Nordic European countries in 2020, cancer diagnoses accounted for 175,925 patients. About 50% of cancer patients receive radiation therapy (RT), which may lead...
Read MoreOff-Label Use of Baricitinib in Dermatology
August 2023 | Volume 22 | Issue 8 | Original Article | 795 | Copyright © August 2023
The current US Food and Drug Administration (FDA) indications for baricitinib include alopecia areata, rheumatoid arthritis, and COVID-19. However, increasing evidence indicates that baricitinib ...
Read MoreDiagnosis and Management of Pediatric Psoriasis: An Overview for Pediatricians
August 2023 | Volume 22 | Issue 8 | Original Article | 742 | Copyright © August 2023
Pediatric psoriasis (PsO) and its associated comorbidities carry physical and psychosocial burdens in children and adolescents, which can negatively impact quality of life. However, features dist...
Read MoreAntimalarials are not Effective as Pre-Exposure Prophylaxis for COVID-19: A Retrospective Matched Control Study
August 2023 | Volume 22 | Issue 8 | Editorials | 840 | Copyright © August 2023
Media and other results for: "chemotherapy"
© 2023 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
